scispace - formally typeset
W

Weihong Zhu

Researcher at East China University of Science and Technology

Publications -  315
Citations -  23285

Weihong Zhu is an academic researcher from East China University of Science and Technology. The author has contributed to research in topics: Dye-sensitized solar cell & Fluorescence. The author has an hindex of 75, co-authored 298 publications receiving 18991 citations. Previous affiliations of Weihong Zhu include Chinese Academy of Sciences & Ewha Womans University.

Papers
More filters
Journal ArticleDOI

Organic sensitizers from D-π-A to D-A-π-A: effect of the internal electron-withdrawing units on molecular absorption, energy levels and photovoltaic performances.

TL;DR: This review is projected to summarize the category of pure organic sensitizers containing additional electron-withdrawing units between electron donors and acceptors on the basis of the D-A-π-A feature by comparing the structure-property relationship of typical photovoltaic dyes.
Journal ArticleDOI

Recent progress on polymer-based fluorescent and colorimetric chemosensors

TL;DR: This tutorial review will cover polymer-based optical chemosensors from 2007 to 2010.
Journal ArticleDOI

Sulfone-containing covalent organic frameworks for photocatalytic hydrogen evolution from water

TL;DR: A crystalline covalent organic framework based on a benzo-bis(benzothiophene sulfone) moiety has now been shown to exhibit high activity for photochemical hydrogen evolution from water.
Journal ArticleDOI

Organic D-A-π-A Solar Cell Sensitizers with Improved Stability and Spectral Response

TL;DR: In this paper, a novel concept "D-A-π-A" organic sensitizer instead of traditional D-π -A ones is proposed, and the incorporated low bandgap, strong electron-withdrawing unit of benzothiadiazole shows several favorable characteristics.
Journal ArticleDOI

In vivo and in situ tracking cancer chemotherapy by highly photostable NIR fluorescent theranostic prodrug.

TL;DR: The tumor-targeting ability and the specific drug release in tumors make DCM-S-CPT as a promising prodrug, providing significant advances toward deeper understanding and exploration of theranostic drug-delivery systems.